HB 30 – Hawaii

Status: Inactive / Dead
Year Introduced: 2021
Link: https://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=HB&billnumber=30&year=2022

Requires certain drug manufacturers to pay monetary penalties to the insurance commissioner for unsupported price increases on prescription drugs sold in the State. Provides for appeals and judicial review. Establishes the identified drug offset special fund. Requires annual reports to the legislature.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found